Leg ulcers can be defined as any wound located above the foot and under the knee. There are a large number of diseases that can induce a leg ulcer: malignancies, vascular, dermatological, metabolic, haematological or infectious diseases. Treatment of leg ulcers is based on two pillars:The first comprises treatment of underlying disease ,and the second encompasses local wound care.



Ankle-brachial pressure index


Venous thrombosis


Extracorporeal shock wave therapy


Micronised purified flavonoid fraction


Negative-pressure wound therapy


Peripheral arterial occlusive disease


Pyoderma gangrenosum


Vacuum-assisted closure


Venoactive drugs


Water-filtered infrared A


  1. Barwell JR, Davies CE, Deacon J, Harvey K, Minor J, Sassano A, Taylor M, Usher J, Wakely C, Earnshaw JJ, Heather BP, Mitchell DC, Whyman MR, Poskitt KR. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet. 2004;363:1854–9.PubMedCrossRefGoogle Scholar
  2. Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Forbes A, Greenwood R, Probert CS. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55(4):505–9.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Chaby G, Senet P, Vaneau M, Martel P, Guillaume JC, Meaume S, Téot L, Debure C, Dompmartin A, Bachelet H, Carsin H, Matz V, Richard JL, Rochet JM, Sales-Aussias N, Zagnoli A, Denis C, Guillot B, Chosidow O. Dressings for acute and chronic wounds: a systematic review. Arch Dermatol. 2007;143(10):1297–304.PubMedCrossRefGoogle Scholar
  4. Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg. 2005;30:198.PubMedCrossRefGoogle Scholar
  5. Cullen B, Smith R, McCulloch E. Mechanism of action of Promogran, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen. 2002;10(1):16–25.PubMedCrossRefGoogle Scholar
  6. Duffy A, Schurr M, Warner T, Chen H. Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol. 2006;13:96–102.PubMedCrossRefGoogle Scholar
  7. Dumville JC, Worthy G, Soares MO, Bland JM, Cullum N, Dowson C, Iglesias C, McCaughan D, Mitchell JL, Nelson EA, Torgerson DJ, VenUS II team. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers. Health Technol Assess. 2009;13(55):1–182.PubMedCrossRefGoogle Scholar
  8. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Glovicski P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–52.PubMedCrossRefGoogle Scholar
  9. Eming S, Krieg T, Davidson J. Gene therapy and wound healing. Clin Dermatol. 2007;25:79–92.PubMedPubMedCentralCrossRefGoogle Scholar
  10. European Wound Management Association (EWMA). Position document: wound bed preparation in practice. London: MEP Ltd; 2004.Google Scholar
  11. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, Jensen J, Sabolinski M, Hardin-Young J. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol. 1998;134(3):293–300.Google Scholar
  12. Falanga V, Iwamoto S, Chartier M, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13:1299–312.PubMedCrossRefGoogle Scholar
  13. Guilhou JJ, Dereure O, Marzin L, et al. Efficacy of Daflon 500 mg on venous ulcer healing: a double blind randomized placebo controlled trail. Angiology. 1997;48:77.PubMedCrossRefGoogle Scholar
  14. Kerk N, Goerge T. Livedoid vasculopathy – current aspects of diagnosis and treatment of cutaneous infarction. J Dtsch Dermatol Ges. 2013;11:407–10.PubMedGoogle Scholar
  15. Miller DR, Enoch S, Williams DT, Price PE, Harding KG. Value of wound biopsy in chronic venous ulceration. Phlebology. 2004;19:65–8.CrossRefGoogle Scholar
  16. Moffat CJ, Franks PJ, Doherty DC, Martin R, Blewett R, Ross F. Prevalence of leg ulceration in a London population. QJM. 2004;97:431–7.CrossRefGoogle Scholar
  17. Neumann M, Cornu-Thénard A, Jünger M, Mosti G, Munte K, Partsch H, Rabe E, Albert-Adrien Ramelet AA, Streit M. Evidence based (S3) Guidelines for diagnostics and treatment of venous leg ulcers. European Dermatology Forum, Update 2014.
  18. O’Meara S, Cullum N, Nelson EA, Dumville JC. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2012;(11):CD000265.PubMedGoogle Scholar
  19. O’Meara S, Martyn-St James M. Alginate dressings for venous leg ulcers. Cochrane Database Syst Rev. 2013a;(4):CD010182.Google Scholar
  20. O’Meara S, Martyn-St James M. Foam dressings for venous leg ulcers. Cochrane Database Syst Rev. 2013b;(5):CD009907.Google Scholar
  21. Ortega-Zilic N, Hunziker T, Läuchli S, Mayer DO, Huber C, Baumann Conzett K, Sippel K, Borradori L, French LE, Hafner J. EpiDex® Swiss field trial 2004–2008. Dermatology. 2010;221(4):365–72.PubMedCrossRefGoogle Scholar
  22. Palfreyman S, Nelson E, Lochiel R, Michaels J. Dressings for healing venous leg ulcers. Cochrane Database Syst Rev. 2006;19, CD001103.Google Scholar
  23. Rabe E, Pannier-Fischer F, Bromen K, Schuldt K, Stang A, Poncar C, Wittenhorst M, Bock E, Weber S, Jöckel KH. Bonner Venenstudie für die Deutsche Gesellschaft für Phlebologie. Phlebologie. 2003;32:1–14.CrossRefGoogle Scholar
  24. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53(2):273–83.PubMedCrossRefGoogle Scholar
  25. Roztocyl K, Stvrtinová V, Strejcek J. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with CVI. Int Angiol. 2003;22:1.Google Scholar
  26. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11 Suppl 1:S1–28.PubMedCrossRefGoogle Scholar
  27. Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen. 2002;10(4):208–14.PubMedCrossRefGoogle Scholar
  28. Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care. 2003;26(2):446–51.PubMedCrossRefGoogle Scholar
  29. Stieger M, Schmid JP, Bajrami S, Hunziker T. Extracorporeal shock wave therapy as a treatment of a non-healing chronic leg ulcer. Hautarzt. 2013;64(6):443–6.PubMedCrossRefGoogle Scholar
  30. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev. 2010;(3):CD006478.Google Scholar
  31. Sunderkotter C, de Groot K. Therapie von Vaskulitiden und Vaskulopathien. Hautarzt. 2008;59:382–93.PubMedCrossRefGoogle Scholar
  32. Tausche AK, Skaria M, Böhlen L, Liebold K, Hafner J, Friedlein H, Meurer M, Goedkoop RJ, Wollina U, Salomon D, Hunziker T. An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen. 2003;11(4):248–52.PubMedCrossRefGoogle Scholar
  33. Veves A, Falanga V, Armstrong DG, Sabolinski ML, Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24(2):290–5.PubMedCrossRefGoogle Scholar
  34. Vojtassák J, Danisovic L, Kubes M, et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett. 2006;27 Suppl 2:134–7.PubMedGoogle Scholar
  35. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56:569–79.PubMedCrossRefGoogle Scholar
  36. Widmer LK, Wandeler JM. Leg complaints and peripheral venous disorders. In: Widmer LK, editor. Peripheral venous disorders (Basle study III). Bern: Hans Huber; 1978. p. 33–42.Google Scholar
  37. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822–7.PubMedCrossRefGoogle Scholar
  38. Wright DD, Franks PJ, Blair SD, et al. Oxerutins in the prevention of recurrence in chronic venous ulceration: a randomized controlled trial. Br J Surg. 1991;78:1269.PubMedCrossRefGoogle Scholar

Further Readings

  1. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol. 2006;1:1161–6.PubMedCrossRefGoogle Scholar
  2. Auböck J. Synthetic dressings. Curr Probl Dermatol. 1999;27:26–48.PubMedCrossRefGoogle Scholar
  3. Bettens S, Delaere B, Glupczynski Y, Schoevaerdts D, Swine C. Ecthyma gangrenosum in a non-neutropenic, elderly patient: case report and review of the literature. Acta Clin Belg. 2008;63:394–7.PubMedCrossRefGoogle Scholar
  4. Binamer Y, Sowerby L, El-Helou T. Treatment of ulcerative necrobiosis lipoidica with topical calcineurin inhibitor: case report and literature review. J Cutan Med Surg. 2012;16(6):458–61.PubMedCrossRefGoogle Scholar
  5. Caputo WJ, Beggs DJ, DeFede JL, Simm L, Dharma H. A prospective randomised controlled clinical trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers. Int Wound J. 2008;5(2):288–94.PubMedCrossRefGoogle Scholar
  6. Conrad C, Trüeb RM. Pyoderma gangrenosum. J Dtsch Dermatol Ges. 2005;3:334–42.PubMedCrossRefGoogle Scholar
  7. Daniel BS, Borradori L, Hall 3rd RP, Murrell DF. Evidence-based management of bullous pemphigoid. Dermatol Clin. 2011;29:613–20.PubMedCrossRefGoogle Scholar
  8. Darvay A, Acland KM, Russell-Jones R. Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin. Br J Dermatol. 1999;141(4):725–7.PubMedCrossRefGoogle Scholar
  9. Dissemond J, Körber A, Grabbe S. Differential diagnosis of leg ulcers. J Dtsch Dermatol Ges. 2006;4:627–34.PubMedCrossRefGoogle Scholar
  10. Enoch S, Miller DR, Price PE, Harding KG. Early diagnosis is vital in the management of squamous cell carcinomas associated with chronic non healing ulcers: a case series and review of the literature. Int Wound J. 2004;1:165–75.PubMedCrossRefGoogle Scholar
  11. Falanga V. Wound bed preparation: science applied to practice. In: European Wound Management Association (EWMA), editor. Position document: wound bed preparation in practice. London: MEP Ltd; 2004.Google Scholar
  12. Greene SL, Su WP, Muller SA. Ecthyma gangrenosum: report of clinical, histopathologic, and bacteriologic aspects of eight cases. J Am Acad Dermatol. 1984;11:781–7.PubMedCrossRefGoogle Scholar
  13. Guillevin L, Lhote F. Classification and management of necrotizing vasculitis. Drugs. 1997;53:805–16.PubMedCrossRefGoogle Scholar
  14. Hafner J, Schaad I, Schneider E, Seifert B, Burg G, Cassina PC. Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol. 2000;43:1001–8.PubMedCrossRefGoogle Scholar
  15. Hafner J, Nobbe S, Partsch H, Läuchli S, Mayer D, Amann-Vesti B, Speich R, Schmid C, Burg G, French LE. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol. 2010;146:961–8.PubMedCrossRefGoogle Scholar
  16. Hairston BR, Davis MD, Gibson LE, Drage LA. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol. 2003;139:987–90.PubMedCrossRefGoogle Scholar
  17. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor Jr LM, White CJ, White J, White RA, Antman EM, Smith Jr SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, ACC/AHA Task Force on Practice Guidelines. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) – summary of recommendation. J Vasc Interv Radiol. 2006;17:1383–97.PubMedCrossRefGoogle Scholar
  18. Howard DPJ, Howard A, Kothari A, Wales L, Guest M, Davies AH. The role of superficial venous surgery in the management of venous ulcers: a systematic review. Eur J Vasc Endovasc Surg. 2008;36:458–65.PubMedCrossRefGoogle Scholar
  19. Jones V, Grey JE, Harding KG. Wound dressings. BMJ. 2006;332(7544):777–80.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;(10):CD002292.Google Scholar
  21. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130:489–93.PubMedCrossRefGoogle Scholar
  22. Leaper DJ, Schultz G, Carville K, Fletcher J, Swanson T, Drake R. Extending the TIME concept: what have we learned in the past 10 years? Int Wound J. 2012;9 Suppl 2:1–19.PubMedCrossRefGoogle Scholar
  23. Lehnen M, Kohaus S, Körber A, Hillen U, Grabbe S, Dissemond J. Contact allergies in patients with chronic wounds: results of a study from 1999 to 2004. Hautarzt. 2006;57(4):303–6.PubMedCrossRefGoogle Scholar
  24. Meissner M, Gille J, Kaufmann R. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome? J Dtsch Dermatol Ges. 2006;4:1037–44.PubMedCrossRefGoogle Scholar
  25. Meurer M. Immunosuppressive therapy for autoimmune bullous diseases. Clin Dermatol. 2012;30:78–83.PubMedCrossRefGoogle Scholar
  26. Moffatt C, Morison MJ, Pina E. Wound bed preparation for venous leg ulcers. In: European Wound Management Association (EWMA), editor. Position document: wound bed preparation in practice. London: MEP Ltd; 2004.Google Scholar
  27. Monney P, Nguyen QV, Perroud H, Descombes E. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant. 2004;19:2130–2.PubMedCrossRefGoogle Scholar
  28. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I. Maggot therapy for the treatment of intractable wounds. Int J Dermatol. 1999;38(8):623–7.PubMedCrossRefGoogle Scholar
  29. Nguyen K, Washenik K, Shupack J. Necrobiosis lipoidica diabeticorum treated with chloroquine. J Am Acad Dermatol. 2002;46(2 Suppl Case Reports):S34–6.PubMedCrossRefGoogle Scholar
  30. Partsch H. Current problems in dermatology, vol. 27. Basel: Karger; 1999.Google Scholar
  31. Patel GK, Harding KG, Mills CM. Severe disabling Koebnerizing ulcerated necrobiosis lipoidica successfully managed with topical PUVA. Br J Dermatol. 2000;143(3):668–9.PubMedCrossRefGoogle Scholar
  32. Ramelet AA. Phlebology, the guide. Paris: Elsevier; 1999.Google Scholar
  33. Ramelet AA. Dermatol Surg. 2002;28:6–10.PubMedGoogle Scholar
  34. Rey S, Sparsa A, Durox H, Allot V, Pommepuy I, Salem A, Roux C, Labrousse F, Bonnetblanc JM. Calciphylaxis treated by cinacalcet: a medical alternative to parathyroidectomy. Rev Med Interne. 2009;30:186–9.CrossRefGoogle Scholar
  35. Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am. 1997;77(3):637–50.PubMedCrossRefGoogle Scholar
  36. Robson M, Mannari R, et al. Maintenance of wound bacterial balance. Am J Surg. 1999;178:399–402.PubMedCrossRefGoogle Scholar
  37. Schliep S, Schuler G, Kiesewetter F. Successful treatment of calciphylaxis with pamidronate. Eur J Dermatol. 2008;18:554–6.PubMedGoogle Scholar
  38. Schumann H, Calow T, Weckesser S, Müller ML, Hoffmann G. Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study. Br J Dermatol. 2011;165(3):541–51.PubMedCrossRefGoogle Scholar
  39. Schuren J, Becker A, Sibbald RG. A liquid film-forming acrylate for peri-wound protection: a systematic review and meta-analysis (3M Cavilon no-sting barrier film). Int Wound J. 2005;2(3):230–8.PubMedCrossRefGoogle Scholar
  40. Scola N, Gäckler D, Stücker M, Kreuter A. Complete clearance of calciphylaxis following combined treatment with cinacalcet and sodium thiosulfate. J Dtsch Dermatol Ges. 2011;9:1030–1.PubMedGoogle Scholar
  41. Shiraishi N, Kitamura K, Miyoshi T, Adachi M, Kohda Y, Nonoguchi H, Misumi S, Maekawa Y, Murayama T, Tomita M, Tomita K. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis. 2006;48:151–4.PubMedCrossRefGoogle Scholar
  42. Stöberl C. Komprimieren: Wann, wie, wozu? In: Partsch H, editor. Phlebologiekurs II. Wien: Facultas Universitätsverlag; 1990. p. 178–88.Google Scholar
  43. Streit M, Mayer D, Traber J. Definitionen und Arten von Wunden: Akute und chronische Wunden. Wund Manage. 2012;3:4–10.Google Scholar
  44. Suárez-Amor O, Pérez-Bustillo A, Ruiz-González I, Rodríguez-Prieto MA. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010;221(2):117–21.PubMedGoogle Scholar
  45. Tan E, Patel V, Berth-Jones J. Systemic corticosteroids for the outpatient treatment of necrobiosis lipoidica in a diabetic patient. J Dermatolog Treat. 2007;18(4):246–8.PubMedCrossRefGoogle Scholar
  46. Torregrosa JV, Durán CE, Barros X, Blasco M, Arias M, Cases A, Campistol JM. Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. Nefrologia. 2012;32:329–34.PubMedGoogle Scholar
  47. Trémezaygues L, Schmaltz R, Vogt T, Reichrath J. Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy. Hautarzt. 2010;61(4):345–53.PubMedCrossRefGoogle Scholar
  48. von Felbert V, Schumann H, Mercer JB, Strasser W, Daeschlein G, Hoffmann G. Therapy of chronic wounds with water-filtered infrared-A (wIRA). GMS Krankenhhyg Interdiszip. 2008;2(2):Doc52.Google Scholar
  49. Wenzel J, Gerdsen R, Phillipp-Dormston W, Bieber T, Uerlich M. Topical treatment of pyoderma gangrenosum. Dermatology. 2002;205:221–3.PubMedCrossRefGoogle Scholar
  50. Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG. Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen. 2005;13(2):131–7.PubMedCrossRefGoogle Scholar
  51. Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature. 1962;193:293–4.PubMedCrossRefGoogle Scholar
  52. Zitt E, König M, Vychytil A, Auinger M, Wallner M, Lingenhel G, Schilcher G, Rudnicki M, Salmhofer H, Lhotta K. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. Nephrol Dial Transplant. 2013;28:1232–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of DermatologyKantonsspital AarauAarauSwitzerland

Personalised recommendations